Share-based Payment Arrangement, Expense in USD of Replimune Group, Inc. from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Replimune Group, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2016 to Q3 2025.
  • Replimune Group, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $8.34M, a 3.61% decline year-over-year.
  • Replimune Group, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $34M, a 0.79% decline year-over-year.
  • Replimune Group, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $35M, a 2.69% increase from 2023.
  • Replimune Group, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $34.1M.
  • Replimune Group, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $7.74M, a 184% increase from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Replimune Group, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $34M $8.34M -$312K -3.61% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $34.3M $8.76M -$713K -7.53% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $35M $8.28M +$356K +4.49% 01 Jan 2025 31 Mar 2025 10-K 22 May 2025
Q4 2024 $34.7M $8.64M +$398K +4.83% 01 Oct 2024 31 Dec 2024 10-Q 12 Feb 2025
Q3 2024 $34.3M $8.65M -$464K -5.09% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 $34.8M $9.48M +$629K +7.11% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 $34.1M $7.92M 01 Jan 2024 31 Mar 2024 10-K 22 May 2025
Q4 2023 $8.24M +$1.22M +17.3% 01 Oct 2023 31 Dec 2023 10-Q 12 Feb 2025
Q3 2023 $9.11M +$2.12M +30.3% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $8.85M +$1.65M +23% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q4 2022 $7.02M +$1.11M +18.7% 01 Oct 2022 31 Dec 2022 10-Q 08 Feb 2024
Q3 2022 $6.99M +$679K +10.8% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 $7.19M +$944K +15.1% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q4 2021 $5.92M +$2.87M +94.1% 01 Oct 2021 31 Dec 2021 10-Q 09 Feb 2023
Q3 2021 $6.31M +$3.51M +125% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 $6.25M +$3.78M +153% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q4 2020 $3.05M 01 Oct 2020 31 Dec 2020 10-Q 03 Feb 2022
Q3 2020 $2.8M 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 $2.47M +$658K +36.4% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q2 2019 $4.32M $1.81M +$1.59M +704% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 $2.73M $882K +$528K +149% 01 Jan 2019 31 Mar 2019 10-K 03 Jun 2020
Q4 2018 $2.2M $881K +$624K +243% 01 Oct 2018 31 Dec 2018 10-Q 14 Feb 2019
Q3 2018 $1.58M $742K +$586K +376% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 $992K $225K +$180K +400% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 $812K $354K 01 Jan 2018 31 Mar 2018 10-K 03 Jun 2020
Q4 2017 $257K 01 Oct 2017 31 Dec 2017 10-Q 14 Feb 2019
Q3 2017 $156K 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $45K 01 Apr 2017 30 Jun 2017 10-Q 30 Aug 2018

Replimune Group, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $35M +$919K +2.69% 01 Apr 2024 31 Mar 2025 10-K 22 May 2025
2023 $34.1M 01 Apr 2023 31 Mar 2024 10-K 22 May 2025
2019 $7.74M +$5.01M +184% 01 Apr 2019 31 Mar 2020 10-K 03 Jun 2020
2018 $2.73M +$1.92M +236% 01 Apr 2018 31 Mar 2019 10-K 03 Jun 2020
2017 $812K +$604K +290% 01 Apr 2017 31 Mar 2018 10-K 03 Jun 2020
2016 $208K 01 Apr 2016 31 Mar 2017 10-K 28 Jun 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.